Recent studies have shown that gastric cancer-driven autocrine CCL2 activates PI3K/Akt/mTOR signaling to suppress proapoptotic autophagy, subsequently promoting sequestosome 1 (SQSTM1)-mediated CCL2 expression via NF-κB signaling. The gene discussed is AKT1; the disease is gastric cancer.